WILSON TROY EDWARD bought RNA
August 6, 2025 · Form 4 insider transaction
WILSON TROY EDWARD bought 22,000 shares of Atrium Therapeutics, Inc. at $12.03 per share, a transaction worth $264.7K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
22,000
Price
$12.03
Total value
$264.7K
InsiderWILSON TROY EDWARD
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 6, 2025
Filing dateAugust 8, 2025
Shares owned after91,425
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
All exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 4, 2024.